Oxidative stress plays important roles in a wide spectrum of pathological p
rocesses, such as atherosclerosis. Although several environmental factors a
re documented to influence redox metabolism, relatively little is known abo
ut genetic effects. In the present study, we evaluated genetic contribution
s to variation in plasma total antioxidant status (TAS), a measure of perox
yl-scavenging capacity, in 1337 members of 40 Mexican American families. TA
S levels were significantly lower in women than in men (1.675 +/-0.004 vers
us 1.805 +/-0.005 mmol/L, respectively; P <0.001), and there was a signific
ant decline of TAS levels with age in men but not in women (P <0.01 for the
interaction). Quantitative genetic analysis indicated the heritability of
TAS levels to be 0.509 +/-0.052; ie, approximate to 51% of the residual var
iance (after covariate adjustment) in TAS levels was due to the additive ef
fects of genes (P <0.001). We have further observed a significant gene-by-s
moking interaction (P <0.05). Additive genetic effects account for 83% of t
he residual phenotypic variance in TAS levels among smokers, but they accou
nt for only 49% in nonsmokers. However, genes contributing to TAS variation
are the same in smokers and nonsmokers. Our study for the first time demon
strates that TAS, an indicator of redox homeostasis, is under strong geneti
c control, especially among smokers. With appropriate tools, such as genome
screening, it should be possible to localize genes that regulate redox hom
eostasis and, ultimately, identify the DNA sequence variants predisposing s
ubjects to oxidative damage.